Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis-a hypothesis

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 133-138

  Flierman, Roelof ^a   Daha, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti C1q autoantibodies; Anti dsDNA autoantibodies; Anti nucleosome autoantibodies; Glomerulonephritis; Lupus nephritis; Renal disease; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C 1 Q AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; GLOMERULONEPHRITIS; HUMAN; HYPOTHESIS; IMMUNE COMPLEX DEPOSITION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOLECULAR RECOGNITION; NUCLEOSOME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; COMPLEMENT C1Q; DNA; HUMANS; LUPUS NEPHRITIS; NUCLEOSOMES;

EID: 33751026236     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.010     Document Type: Article

References (52)

1. Agnello V., Koffler D., Eisenberg J.W., Winchester R.J., and Kundel H.G. C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J. Exp. Med. 134 (1971) 228s-241s
2. Amoura Z., Piette J.C., Chabre H., Cacoub P., Papo T., Wechsler B., Bach J.F., and Koutouzov S. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 40 (1997) 2217-2225
3. Antes U., Heinz H.P., and Loos M. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum. 31 (1988) 457-464
4. Arbuckle M.R., James J.A., Kohlhase K.F., Rubertone M.V., Dennis G.J., and Harley J.B. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 54 (2001) 211-219
5. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., and Harley J.B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 (2003) 1526-1533
6. Bagavant H., Deshmukh U.S., Gaskin F., and Fu S.M. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand. J. Immunol. 60 (2004) 52-63
7. Berden J.H. Lupus nephritis. Kidney Int. 52 (1997) 538-558
8. Berden J.H. Lupus nephritis: consequence of disturbed removal of apoptotic cells?. Neth. J. Med. 61 (2003) 233-238
9. Bruns A., Blass S., Hausdorf G., Burmester G.R., and Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 43 (2000) 2307-2315
10. Burlingame R.W., Boey M.L., Starkebaum G., and Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94 (1994) 184-192
11. Burlingame R.W., and Cervera R. Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmun. Rev. 1 (2002) 321-328
12. Cervera R., Vinas O., Ramos-Casals M., Font J., Garcia-Carrasco M., Siso A., Ramirez F., Machuca Y., Vives J., Ingelmo M., and Burlingame R.W. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann. Rheum. Dis. 62 (2003) 431-434
13. Coremans I.E., Spronk P.E., Bootsma H., Daha M.R., van der Voort E.A., Kater L., Breedveld F.C., and Kallenberg C.G. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am. J. Kidney Dis. 26 (1995) 595-601
14. Faaber P., Rijke T.P., van de Putte L.B., Capel P.J., and Berden J.H. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulphate. The major glycosaminoglycan in glomerular basement membranes. J. Clin. Invest. 77 (1986) 1824-1830
15. Fremeaux-Bacchi V., Noel L.H., and Schifferli J.A. No lupus nephritis in the absence of antiC1q autoantibodies?. Nephrol. Dial. Transplant. 17 (2002) 2041-2043
16. Gunnarsson I., Ronnelid J., Huang Y.H., Rogberg S., Nilsson B., Lundberg I., and Klareskog L. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br. J. Rheumatol. 36 (1997) 32-37
17. Hahn B.H. Antibodies to DNA. N. Engl. J. Med. 338 (1998) 1359-1368
18. Horvath L., Czirjak L., Fekete B., Jakab L., Pozsonyi T., Kalabay L., Romics L., Miklos K., Varga L., Prohaszka Z., Szakacs A., Nagy E., Daha M.R., and Fust G. High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin. Exp. Rheumatol. 19 (2001) 667-672
19. Kramers C., Hylkema M.N., Vanbruggen M.C.J., Vandelagemaat R., Dijkman H.B.P.M., Assmann K.J.M., Smeenk R.J.T., and Berden J.H.M. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-Dna reactivity and bind to rat glomerular-basement-membrane in-vivo. J. Clin. Invest. 94 (1994) 568-577
20. Lipsky P.E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat. Immunol. 2 (2001) 764-766
21. Lu L., Kaliyaperumal A., Boumpas D.T., and Datta S.K. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J. Clin. Invest. 104 (1999) 345-355
22. Manderson A.P., Botto M., and Walport M.J. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22 (2004) 431-456
23. Marto N., Bertolaccini M.L., Calabuig E., Hughes G.R., and Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 64 (2005) 444-448
24. Marto N., Bertolaccini M.L., Calabuig E., Hughes G.R., and Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 64 (2005) 444-448
25. Mills J.A. Systemic lupus erythematosus. N. Engl. J. Med. 330 (1994) 1871-1879
26. Min D.J., Kim S.J., Park S.H., Seo Y.I., Kang H.J., Kim W.U., Cho C.S., and Kim H.Y. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin. Exp. Rheumatol. 20 (2002) 13-18
27. Mok C.C., and Lau C.S. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56 (2003) 481-490
28. Moroni G., Trendelenburg M., Del Papa N., Quaglini S., Raschi E., Panzeri P., Testoni C., Tincani A., Banfi G., Balestrieri G., Schifferli J.A., Meroni P.L., and Ponticelli C. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am. J. Kidney Dis. 37 (2001) 490-498
29. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., and Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76 (2000) 227-324
30. Rumore P.M., and Steinman C.R. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 86 (1990) 69-74
31. Seelen M.A., Trouw L.A., and Daha M.R. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr. Opin. Nephrol. Hypertens. 12 (2003) 619-624
32. Siegert C., Daha M., Westedt M.L., van d.V., and Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J. Rheumatol. 18 (1991) 230-234
33. Siegert C.E., Daha M.R., Halma C., van der Voort E.A., and Breedveld F.C. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin. Exp. Rheumatol. 10 (1992) 19-23
34. Siegert C.E., Daha M.R., Swaak A.J., van der Voort E.A., and Breedveld F.C. The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 67 (1993) 204-209
35. Siegert C.E., Daha M.R., Tseng C.M., Coremans I.E., van Es L.A., and Breedveld F.C. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann. Rheum. Dis. 52 (1993) 851-856
36. Simon J.A., Cabiedes J., Ortiz E., Alcocer-Varela J., and Sanchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford) 43 (2004) 220-224
37. Tax W.J., Kramers C., van Bruggen M.C., and Berden J.H. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int. 48 (1995) 666-673
38. ter Borg E.J., Horst G., Hummel E.J., Limburg P.C., and Kallenberg C.G. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 33 (1990) 634-643
39. Trendelenburg M. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin. Immunopathol. 27 (2005) 276-285
40. Trendelenburg M., Marfurt J., Gerber I., Tyndall A., and Schifferli J.A. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum. 42 (1999) 187-188
41. Trouw L.A., and Daha M.R. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis. Expert. Opin. Biol. Ther. 5 (2005) 243-251
42. Trouw L.A., Roos A., and Daha M.R. Autoantibodies to complement components. Mol. Immunol. 38 (2001) 199-206
43. Trouw L.A., Duijs J.M., van Kooten C., and Daha M.R. Immune deposition of C1q and anti-C1q antibodies in the kidney is dependent on the presence of glomerular IgG. Mol. Immunol. 40 (2003) 595-602
44. Trouw L.A., Seelen M.A., Duijs J.M., Benediktsson H., van Kooten C., and Daha M.R. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin. Exp. Immunol. 132 (2003) 32-39
45. Trouw L.A., Groeneveld T.W., Seelen M.A., Duijs J.M., Bajema I.M., Prins F.A., Kishore U., Salant D.J., Verbeek J.S., van Kooten C., and Daha M.R. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 114 (2004) 679-688
46. Uwatoko S., Aotsuka S., Okawa M., Egusa Y., Yokohari R., Aizawa C., and Suzuki K. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 69 (1987) 98-106
47. Uwatoko S., and Mannik M. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J. Clin. Invest. 82 (1988) 816-824
48. van Bruggen M.C., Walgreen B., Rijke T.P., Tamboer W., Kramers K., Smeenk R.J., Monestier M., Fournie G.J., and Berden J.H. Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur. J. Immunol. 27 (1997) 1564-1569
49. Voll R.E., Roth E.A., Girkontaite I., Fehr H., Herrmann M., Lorenz H.M., and Kalden J.R. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 40 (1997) 2162-2171
50. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
51. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 344 (2001) 1140-1144
52. Walport M.J. Complement and systemic lupus erythematosus. Arthritis Res. 4 Suppl 3 (2002) S279-S293